Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0000950170-25-110773

President & CEO sold 1,573 shares at $26.59 ($41,826)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBIN HOWARD W President & CEO 2025-08-19 Sale −1,573 $26.59 $41,826 69,340 D: show line 1 in the form
Open-market sales · 1,573 sh · avg $26.59 · $41,826

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
ROBIN HOWARD W President & CEO 2025-08-19 Grant or award · Stock Option +86,666 86,666 D: show line 2 in the form
Loading xslF345X05/ownership.xml…